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Choice of Statistical Tools for Outlier Removal Causes
Substantial Changes in Analyte Reference Intervals in
Healthy Populations
Peter E. Hickman,a,b Gus Koerbin,c Julia M. Potter,a,b Nicholas Glasgow,a Juleen A. Cavanaugh,a
Walter P. Abhayaratna,c Nic P. West,d and Paul Glaszioue,*
BACKGROUND: Reference intervals are an important aid
in medical practice as they provide clinicians a guide as
to whether a patient is healthy or diseased.
Outlier results in population studies are removed by
any of a variety of statistical measures. We have com-
pared several methods of outlier removal and applied
them to a large body of analytes from a large population
of healthy persons.
METHODS: We used the outlier exclusion criteria of
Reed-Dixon and Tukey and calculated reference inter-
vals using nonparametric and Harrell-Davis statistical
methods and applied them to a total of 36 different
analytes.
RESULTS: Nine of 36 analytes had a greater than 20%
difference in the upper reference limit, and for some the
difference was 100% or more.
CONCLUSIONS: For some analytes, great importance is at-
tached to the reference interval. We have shown that
different statistical methods for outlier removal can
cause large changes to reported reference intervals. So
that population studies can be readily compared, com-
mon statistical methods should be used for outlier
removal.
Comparison is an important element of clinical medi-
cine, with clinicians using quantitative benchmarks for
normality to assess how a particular case may be differ-
ent and abnormal. In the clinical laboratory, reference
intervals for analytes act as this benchmark because they
provide an objective measure as to whether homeostasis
is normal.
Typically, the central 95th percentile of a healthy
population is used to define reference intervals, although
there are important exceptions such as the 99th percen-
tile for troponin (1) and the use of decision limits rather
than reference intervals for some analytes such as choles-
terol and hemoglobin A1c (2).
Even when assessing an objectively healthy popula-
tion, there are invariably a few outlier results, and use of
a variety of empirical procedures to remove these out-
liers has become accepted practice (3–5).
A recent article by Eggers showed that the 99th per-
centile for troponin was markedly different, depending
upon which method for outlier removal was chosen (6).
We have replicated their findings using data from our
large Canberra Heart Study database (7).
The problem of outlier removal is not unique to
troponin and the 99th percentile (8). We have explored
our large Aussie Normals database which we used to es-
tablish reference intervals for a large number of general
chemistry analytes (9) and thyroid hormones (10) and
report on the effect of different statistical methods for
outlier removal on derived reference intervals for all
these analytes.
Materials and Methods
Different parts of this study were approved by the
Australian Capital Territory (ACT) Health Human
Research Ethics Committee, the Australian National
University Human Research Ethics Committee, or the
Australian Institute of Sport Research Ethics
Committee.
POPULATION STUDIED
Details of the recruitment into, and running of the
Aussie Normals study have been published in detail else-
where (9). Briefly, a total of 1856 persons were recruited
largely by invitation of persons selected from the local
electoral roles as typical of the ACT demographic, and
by advertising in local media. We excluded persons who
were pregnant or had diabetes mellitus, asthma requir-
ing oral steroids, any history of malignancy and other
conditions involving systemic disease known to bias
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biochemical concentrations. We accepted persons taking
statins, the oral contraceptive pill, or hormone replace-
ment therapy, and analytes affected by these medica-
tions were excluded from analysis.
LABORATORY METHODS
Thirty-six (36) routine laboratory assays were assessed
using proprietary methods and performed on either an
Abbott Architect ci8200 or ci16200, Metrological trace-
ability is described by the manufacturer in its informa-
tion for users (IFU). Hemolysis (H), icterus (I), and
lipemia (L) was assessed on all samples using on-board
HIL automated procedures.
The performance characteristics for the assays
showed coefficients of variation (CVs) ranging from
0.8% to 5.5% for kidney, liver, bone minerals, specific
protein, and iron analysis. Homocysteine showed a CV
of <8% with thyroid stimulating hormone (TSH) and
free thyroxine (FT4) <4.9% and free triiodothyronine
(FT3) <15%.
STATISTICAL METHODS
Evaluation of the 36 reference intervals from the Aussie
Normals study was undertaken using the outlier exclu-
sion criteria of Reed-Dixon (5, 11, 12) and Tukey (12)
using 1.5 and 3.0 IQR fence criteria. Reference inter-
vals were calculated using nonparametric (Analyse-it
Software, Ltd.) and Harrell Davis statistical methods
(13). The differences in upper and lower reference lim-
its (URL, LRL) were then compared against biological
variation CVi, as shown by Westgard using the 2012
updated Ricos data (14) and the allowable limits
of performance used by the Royal College of
Pathologists of Australasia Quality Assurance Program
(RCPAQAP) (15).
Results
Of the reference intervals calculated, 27/36 showed little
difference when the 3 outlier exclusion criteria and
statistical methods were compared. Those analytes were
sodium, potassium, chloride, bicarbonate, urea, total
and direct bilirubin, total protein, albumin, uric acid,
creatinine, lactate dehydrogenase (LD), alkaline phos-
phatase (ALP), calcium, magnesium, phosphate, C3,
C4, alpha-1 antitrypsin, immunoglobulin G (IgG),
haptoglobin, iron, transferrin, ferritin (women), homo-
cysteine (women), FT4, and FT3.
Using the Tukey 1.5 x IQR fence exclusion criteria
as the reference method, lipase, IgA, IgM, alanine trans-
aminase (ALT), creatine kinase (CK), homocysteine
(men), ferritin (men), TSH, and amino terminal pro-B-
type natriuretic peptide (NT-proBNP) showed differen-
ces, (higher URL results) when compared with Reed
Dixon and the 3.0 IQR fence exclusion method with
both nonparametric Harrell Davis statistical analysis.
Aspartate transaminase (AST) and gamma glutamyl
transpeptidase (GGT) only showed statistical differences
against the Reed Dixon criteria (higher URL). The nu-
merical differences are shown in Table 1. The URL’s for
creatine kinase (CK) (women) and GGT (men and
women) using the Tukey exclusion criteria showed dif-
ferences between the nonparametric and Harrell Davis
analysis when compared with the CVi and RCPAQAP
allowable limits. No statistical differences in URLs were
seen between the nonparametric and Harrell Davis
analysis when using the Reed Dixon exclusion criteria.
No differences were seen in the LRLs between the
nonparametric and Harrell Davis statistical methods us-
ing the Reed Dixon or Tukey 1.5 IQR fence criteria
except for creatinine using the Tukey 1.5 IQR fence
criteria with both male and female ranges showing
results that were 20% lower using the Harrell Davis sta-
tistical method.
Discussion
Using a large population of healthy persons, we have
shown that for several very important analytes, the
choice of statistical method used for outlier removal
causes a substantial change in either the upper or lower
boundary of the reference interval. The Tukey method
typically led to a narrower reference interval. A Tukey
fence of 1.5 IQR is approximately equivalent to 3
SDs or 1%, and hence will remove about 1% even from
a truly healthy population. Hence this outlier exclusion
means a 95% reference range is effectively a 94% refer-
ence range—with 6% being classed as abnormal
(1% from the fence; 5% from the definition). Thus
with Tukey we would be looking at a reference interval
of 3.0%–97.0%. For a 99% reference interval, the
Tukey fence implies a 98% equivalent—or 2% (1%
from the fence; 1% from the definition of a 99% inter-
val), so the reference interval would become 0.5–98.5%
or <98.5%. Some statistical methods have been devel-
oped to adjust for this exclusion problem (16).
Twenty-seven of 36 analytes showed little differ-
ence in derived reference intervals, regardless of which
statistical method is used. Analytes with tight physiolog-
ical control (e.g, sodium) have a much smaller spread
compared with analytes such as transaminases. It is these
latter analytes that are more likely to be affected by
different statistical manipulations.
Defining a truly healthy population is problematic.
Age is associated with a higher troponin 99th percentile,
even in healthy persons who have gone through rigorous
health checks (17). Mild obesity is associated with
higher ALT activity in apparently healthy men and
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women (9). Even low levels of activity can cause
increases in CK activity. As there is often a gradual tran-
sition from health to disease, it is very difficult to ensure
that all persons included are truly healthy.
Considerable importance can be attached to
reference intervals. Examples are NT-proBNP used
for the defining of persons with heart failure (18), fer-
ritin for assessing persons with possible hemochroma-
tosis (19), and TSH is of considerable concern in
looking at women with possible mild thyroid disease
in pregnancy (20). ALT reference intervals are of
importance in assessing persons with mild hepato-
cellular disease, especially the effect of alcohol (21).
Currently, quoted ALT reference intervals for men
can vary as widely as 10–68 (22) and 10–41 (9).
Similar discord is seen with reference intervals for
women. The American College of Gastroenterologists
have recommended an upper reference limit for men
of 33 and for women of 25 (21), using the rationale
that no cases of pathology should be missed, but at
the risk of gross overinvestigation of many persons
without pathology. The substantial overlap in results
between healthy persons and those with some degree
of liver pathology means no quoted reference interval
will satisfy all parties.
The Clinical and Laboratory Standards Institute
(CLSI) has published a detailed monograph on estab-
lishing reference intervals (5). They have concentrated
on the choice and sampling of the healthy population
used for establishing a reference interval and to a lesser
extent with the statistical treatment of data. This article
indicates that the statistical method can make a consid-
erable difference, and hence is a matter of importance
for all analytes. The CLSI should develop a position
statement on the preferred statistical treatment for out-
lier removal so that population studies can be meaning-
fully compared.
Nonstandard Abbreviations: LRL, lower reference limit; URL, upper
reference limit; CLSI, Clinical and Laboratory Standards Institute;
RCPAQAP, Royal College of Pathologists of Australasia Quality
Assurance Program
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Table 1. Reference intervals for 9 of 36 analytes using Harrel-Davis analysis and Tukey or Reed-Dixon exclusion criteria for
eliminating outliers where a difference of >20% in Upper Reference Limit (URL) was observed between exclusion
methods.
Tukey (1.5 IQR) Tukey (3.0 IQR) Reed Dixon exclusion
Non parametric Harrell Davis Non parametric Harrell Davis Non parametric Harrell Davis
NT-proBNP (ng/L)# 6 – 246 6–249 6–341 6–342 6–1017 6–1035
ALT (M) (U/L) 10 – 41 11–40 11–49 10–48 11–53 10–48
ALT (F) (U/L) 9–33 8–31 8–39 8–40 8–44 8–45
AST (M) (U/L) 14–35 15–33 14–37 14–38 14–44 14–44
AST (F) (U/L) 13–32 13–31 13–35 13–35 13–39 13–39
GGT (M) (U/L) 12–71 10–57 12–79 12–80 12–101 12–108
GGT (F) (U/L) 9–56 9–43 9–63 9–64 9–88 9–90
Homocysteine (M) (mmol/L) 7.6–16.5 7.6–15.5 7.7–18.3 7.7–18.4 7.7–19.2 7.6–19.4
CK (M) (U/L) 49–252 49–266 50–314 49–321 50–360 49–376
CK (F) (U/L) 37–221 36–182 37–229 37–230 37–278 36–290
Ferritin (M) (mg/L) 20–318 20–312 20–425 21–432 21–432 21–434
TSH (MþF) (mU/L) 0.42–2.67 0.42–2.68 0.43–3.41 0.42–3.41 0.43–3.39 0.42–3.41
cTnI (M) (ng/L) <6.0a <6.6a <9.1a <9.7a <27.3a <22.8a
cTnI (F) (ng/L) <5.7a <5.9a <9.7a <9.7a <13.1a <15.0a
acTnI 99th percentile.
#Abbreviations: NT-proBNP—amino terminal pro-B-type natriuretic peptide; ALT—alanine transaminase; AST—aspartate transaminase; GGT—gamma glutamyl transpeptidase; CK—
creatine kinase; TSH—thyroid stimulating hormone; cTnI—cardiac troponin I.
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